Dollars for Docs

How Industry Dollars Reach Your Doctors

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

LAKSHMI P KANNAN
Is This Your Doctor?
Print out this record, along with questions and tips for talking with your physician about payments.
Have you used or plan to use this information? Tell us about it.

LAKSHMI P KANNAN

Listed Specialty: Hematology & Oncology
3555 WEST WHEATLAND ROAD, DALLAS, TX, 75237
Search this name in Dollars for Docs Archive →
Is this you? Do you believe the data contains errors? Click here for information →
Is This Your Doctor?
Print out this record, along with questions and tips for talking with your physician about payments.
Have you used or plan to use this information? Tell us about it.

DR. LAKSHMI KANNAN,
Yearly Payment Breakdown:

2018 Payments At a Glance

21

payments

$10,490

payment total

7

companies paid this doctor

Payment Calendar in 2018

This doctor received a payment on days in 2018.

Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.

2018

Types of Payments in 2018

Category Payments Payment Value
Consulting
 3 $8,000
Travel and Lodging
 7 $1,892
Food and Beverage
 11 $598

Drugs & Devices in 2018

Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.

Product Name Product Type Payments†
FEDRATINIB

drug

 $5,896
AURYXIA

drug

 $4,081
Payments with no listed product

N/A

 $335
NERLYNX

drug

 $119
RUBRACA

drug

 $26
MOLECULAR REAGENTS/TEST KIT/CLINICAL UTILIZATION

device

 $19
JEVTANA

drug

 $14
PROSTATE CANCER - DISEASE

drug

 $14
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products.

Payment Details in 2018

When How Much Related To What For From Third Party Payee
Nov 7, 2018 $5,005 FEDRATINIB Consulting CELGENE CORPORATION
Jul 2, 2018 $2,660 AURYXIA Consulting KERYX BIOPHARMACEUTICALS, INC.
Jun 22, 2018 $708 AURYXIA Travel and Lodging KERYX BIOPHARMACEUTICALS, INC.
Oct 26, 2018 $365 FEDRATINIB Travel and Lodging CELGENE CORPORATION
Oct 26, 2018 $360 FEDRATINIB Travel and Lodging CELGENE CORPORATION
Apr 17, 2018 $335 No Listed Product Consulting INCYTE CORPORATION
Jun 22, 2018 $227 AURYXIA Travel and Lodging KERYX BIOPHARMACEUTICALS, INC.
Jun 22, 2018 $150 AURYXIA Food and Beverage KERYX BIOPHARMACEUTICALS, INC.
Jun 23, 2018 $128 AURYXIA Travel and Lodging KERYX BIOPHARMACEUTICALS, INC.
Feb 5, 2018 $119 NERLYNX Food and Beverage PUMA BIOTECHNOLOGY, INC.
Dec 20, 2018 $72 FEDRATINIB Food and Beverage CELGENE CORPORATION
Jul 2, 2018 $61 AURYXIA Travel and Lodging KERYX BIOPHARMACEUTICALS, INC.
Oct 26, 2018 $52 FEDRATINIB Food and Beverage CELGENE CORPORATION
Jun 23, 2018 $43 AURYXIA Food and Beverage KERYX BIOPHARMACEUTICALS, INC.
Jun 23, 2018 $43 AURYXIA Food and Beverage KERYX BIOPHARMACEUTICALS, INC.
Dec 20, 2018 $43 FEDRATINIB Travel and Lodging CELGENE CORPORATION
Jun 23, 2018 $38 AURYXIA Food and Beverage KERYX BIOPHARMACEUTICALS, INC.
Jun 14, 2018 $26 RUBRACA Food and Beverage CLOVIS ONCOLOGY, INC.
Jul 2, 2018 $22 AURYXIA Food and Beverage KERYX BIOPHARMACEUTICALS, INC.
Aug 17, 2018 $19 MOLECULAR REAGENTS/TEST KIT/CLINICAL UTILIZATION Food and Beverage SIEMENS MEDICAL SOLUTIONS USA, INC.
Aug 24, 2018 $14 JEVTANA PROSTATE CANCER - DISEASE Food and Beverage GENZYME CORPORATION
See this doctor’s Open Payments page →

Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].

This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.